Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism.

Tristan Greilsamer, Claire Blanchard, Niki Christou, Delphine Drui, Catherine Ansquer, Maelle Le Bras, Bertrand Cariou, Cécile Caillard, Emmanuelle Mourrain-Langlois, Anne Sophie Delemazure, Muriel Mathonnet, Françoise Kraeber-Bodéré, Eric Mirallié
Author Information
  1. Tristan Greilsamer: Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalier Universitaire (CHU) Nantes-Hôtel Dieu, Place Alexis Ricordeau, 44093, Nantes, France.

Abstract

INTRODUCTION: Parathyroid sestamibi scan is routinely performed before parathyroid surgery. A large number of thyroid cancers take up 99mTc-sestamibi (MIBI). Since 2001, thyroid nodules discovered on sestamibi, nodules >2 cm, and/or with suspicious criteria were resected. The aim of this study was to evaluate the results of this policy.
METHODS: All patients operated on for hyperparathyroidism, with a MIBI and cervical ultrasonography (US) with a thyroid resection for nodule, were retrospectively included.
RESULTS: From 2001 to 2013, 685 patients were operated on for hyperparathyroidism. Some 137 (85 % females) had both preoperative MIBI and cervical US and a thyroid resection. The mean age was 63.2 ± 12.8 years. Sixty-three patients had a total thyroidectomy and 74 a lobectomy. Thirty-six patients had a thyroid cancer. The median size of cancers was 6.5 mm (0.3-22 mm), and 23 (16.7 %) patients had microcarcinoma. Among the 137 patients, 44 (32 %) had a MIBI+ nodule including 22 cancers. Sixty-one percent of malignant nodules were MIBI+ (22/36). The median size of MIBI+ cancers was 15 mm (9-22 mm) versus 2 mm (0.3-17 mm) for MIBI- cancers (p = 0.03). Twenty-two percent of benign nodules were MIBI+ (22/101). Finally, the sensitivity, specificity, positive predictive value, and negative predictive value of MIBI were 61, 78, 50, and 85 %, respectively.
CONCLUSION: Thyroid nodules incidentally discovered on MIBI in hyperparathyroidism patients should be resected.

References

  1. J Clin Endocrinol Metab. 2009 May;94(5):1748-51 [PMID: 19276237]
  2. Ann R Coll Surg Engl. 2011 May;93(4):290-3 [PMID: 21944794]
  3. Langenbecks Arch Surg. 2009 Sep;394(5):761-4 [PMID: 19575214]
  4. World J Surg. 2008 Nov;32(11):2509-15 [PMID: 18758853]
  5. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1497-500 [PMID: 24705621]
  6. Clin Endocrinol (Oxf). 2012 May;76(5):749-58 [PMID: 22078001]
  7. J Endocrinol Invest. 2010;33(5 Suppl):51-6 [PMID: 20543551]
  8. Am J Otolaryngol. 2004 Sep-Oct;25(5):308-12 [PMID: 15334393]
  9. Cancer Biother Radiopharm. 2006 Dec;21(6):579-90 [PMID: 17257073]
  10. Nucl Med Commun. 2014 Jan;35(1):51-7 [PMID: 24128898]
  11. Langenbecks Arch Surg. 2010 Sep;395(7):935-40 [PMID: 20694475]
  12. Ann Surg Oncol. 2012 May;19(5):1446-52 [PMID: 22395991]
  13. Thyroid. 2014 Jul;24(7):1115-20 [PMID: 24684285]
  14. Langenbecks Arch Surg. 2010 Sep;395(7):929-33 [PMID: 20625763]
  15. Langenbecks Arch Surg. 2011 Jan;396(1):83-90 [PMID: 21061130]
  16. J Clin Endocrinol Metab. 2014 Aug;99(8):2834-43 [PMID: 24828487]
  17. J Radiol. 2011 Jul-Aug;92 (7-8):701-13 [PMID: 21819912]
  18. Surgery. 2013 Dec;154(6):1232-7; discussion 1237-8 [PMID: 24383100]
  19. Head Neck. 2010 May;32(5):607-11 [PMID: 19693945]
  20. Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):577-8 [PMID: 24346412]
  21. Ann Endocrinol (Paris). 2011 Sep;72 (4):251-281 [PMID: 21782154]
  22. PLoS One. 2013 Oct 24;8(10 ):e77927 [PMID: 24205031]
  23. AJR Am J Roentgenol. 2014 Apr;202(4):W379-89 [PMID: 24660737]
  24. Cancer. 2002 Oct 15;95(8):1611-7 [PMID: 12365007]
  25. Eur J Endocrinol. 2012 Dec 10;168(1):49-58 [PMID: 23093696]
  26. Endocrine. 2013 Aug;44(1):70-8 [PMID: 23529672]

MeSH Term

Female
Humans
Hyperparathyroidism, Primary
Incidental Findings
Male
Middle Aged
Predictive Value of Tests
Radionuclide Imaging
Radiopharmaceuticals
Retrospective Studies
Sensitivity and Specificity
Technetium Tc 99m Sestamibi
Thyroid Neoplasms
Thyroid Nodule
Thyroidectomy
Ultrasonography

Chemicals

Radiopharmaceuticals
Technetium Tc 99m Sestamibi

Word Cloud

Created with Highcharts 10.0.0patientsthyroidMIBInodulesmmcancershyperparathyroidism%MIBI+discoveredsestamibi2001resectedoperatedcervicalUSresectionnodule13785mediansize0percentpredictivevalueincidentallyINTRODUCTION:Parathyroidscanroutinelyperformedparathyroidsurgerylargenumbertake99mTc-sestamibiSince>2cmand/orsuspiciouscriteriaaimstudyevaluateresultspolicyMETHODS:ultrasonographyretrospectivelyincludedRESULTS:2013685femalespreoperativemeanage632 ± 128yearsSixty-threetotalthyroidectomy74lobectomyThirty-sixcancer653-2223167microcarcinomaAmong4432including22Sixty-onemalignant22/36159-22versus23-17MIBI-p = 003Twenty-twobenign22/101Finallysensitivityspecificitypositivenegative617850respectivelyCONCLUSION:ThyroidManagementscanningprimary

Similar Articles

Cited By